Prescribing Benzodiazepines for Patients with History of Substance Abuse and Anxiety Disorders
Benzodiazepines should generally be avoided in patients with a history of substance abuse, even if they have an anxiety disorder that responds to these medications, due to the high risk of dependence, addiction, and potential for misuse.
Risk Assessment Framework
When considering benzodiazepine therapy for patients with both anxiety disorders and substance abuse history, a careful risk-benefit analysis is essential:
High-Risk Factors
- Active substance use disorder
- Polysubstance abuse (especially with opioids)
- Prior benzodiazepine misuse
- Severe liver disease
- Respiratory issues
- History of seizures
Risk Stratification Process
Evaluate substance use history:
- Duration since last substance use
- Type of substances previously abused
- Treatment history and recovery status
- Current abstinence verification
Assess anxiety disorder:
- Severity of symptoms
- Impact on functioning
- Previous treatment responses
- Alternative treatment options tried
Evidence-Based Recommendations
The 2017 HIVMA/IDSA clinical practice guideline clearly states that "a patient's history of addiction or substance use disorder is not an absolute contraindication to receiving controlled substances for the management of chronic pain" 1. This principle can be extended to anxiety management, but requires careful risk stratification.
For Lower-Risk Patients:
If benzodiazepines are considered necessary after exhausting alternatives:
- Use the lowest effective dose for the shortest duration possible 2
- Implement a structured monitoring program with:
- Regular face-to-face visits
- Urine drug screening
- Prescription monitoring program checks
- Clear treatment agreements
For Higher-Risk Patients:
When risks outweigh benefits:
- Utilize non-benzodiazepine anxiety treatments:
- SSRIs/SNRIs for long-term anxiety management
- Buspirone for generalized anxiety
- Hydroxyzine for acute anxiety
- Pregabalin/gabapentin (with caution)
- CBT and other psychotherapeutic approaches
Tapering Considerations
If a patient with substance abuse history is already taking benzodiazepines:
- Develop a structured tapering plan:
Special Considerations
Concurrent Opioid Use
FDA black box warnings highlight that "concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death" 2. This combination should be strictly avoided in patients with substance abuse history.
Elderly Patients
The 2019 AGS Beers Criteria recommends avoiding benzodiazepines in older adults due to increased sensitivity and risk of cognitive impairment, delirium, falls, fractures, and motor vehicle accidents 1.
Monitoring Requirements
For patients where benzodiazepines are deemed necessary despite history:
- Weekly contact during active treatment 3
- Regular assessment for signs of misuse, tolerance, or dose escalation
- Consider referral for substance use evaluation
Common Pitfalls to Avoid
Indefinite prescribing: Benzodiazepines should be prescribed for the shortest possible duration with a clear exit strategy.
Inadequate monitoring: Patients with substance abuse history require more frequent monitoring than the general population.
Overlooking alternatives: Non-benzodiazepine treatments should be exhausted before considering benzodiazepines.
Ignoring warning signs: Early signs of misuse or diversion should prompt immediate reevaluation of the treatment plan.
Abrupt discontinuation: Always taper benzodiazepines to avoid withdrawal symptoms, which can be life-threatening 2.
While some older research suggests benzodiazepines may be appropriate for certain patients with past substance abuse 4, more recent evidence and guidelines emphasize the substantial risks. The potential for dependence, abuse, and addiction makes benzodiazepines particularly problematic in this vulnerable population, and alternative treatments should be strongly preferred.